iLoF

iLoF

Private
LondonHealthcare & Life Scienceshttps://ilof.tech/

Last Round

SAFE

Mar 9, 2026

Total Funding Raised

$12.67M

Momentum Score

25 /100

Company Overview

iLoF is a digital health company with an AI and photonics platform that creates a digital library of biomarkers to accelerate personalized drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

biomarker discoverypatient stratificationclinical trial optimizationAI drug discoverydigital biomarkerspatient screeningprecision medicinephotonicsnon-invasive screeningoptical fingerprintsdrug development toolsmedical AIbiomarker libraryAlzheimer's diseaseneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iLoF Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

iLoF Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SAFEMar 9, 2026
StrategicOct 22, 2024
GrantJul 31, 2024
AcceleratorJan 1, 2023
SeedJul 28, 2022
Grant
Jul 28, 2022

Key People

Founding team and executive leadership

Mehak Mumtaz

COO & Co-Founder

Founding Team

Bernardo Alba

Founders Senior Associate CEO Office

Founding Team

Luis Valente

CEO & Co-Founder

Founding Team

iLoF Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 9, 2026

    $231K raised from Hamamatsu Ventures, M12, and others.

  • Feb 19, 2026

    Grew 30% QoQ, from 30 to 39 employees.

iLoF Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iLoF Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iLoF's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range39
Year Founded2019
Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.